Molecular

Nov. 6, 2024

Q&A with Nathan Patton, vice president of marketing for Near Patient Care at Roche Diagnostics

MLO Staff

Oct. 30, 2024

Q&A with Jackie Weiss, PhD, scientific affairs liaison at EUROIMMUN US (part of Revvity)

MLO Staff

Oct. 29, 2024

Precision Medicine

NIH clinical trial will test precision medicine treatments for myeloid cancers

Oct. 29, 2024

Genomics

Genomic variants that increase risk of kidney disease are found in nearly one-third of West Africans

Oct. 29, 2024

MLO releases findings of 2024 SOI survey on MDx

Kara Nadeau

Oct. 28, 2024

More quality assurance measures enacted, greater concerns over LDT access, fewer supply chain issues reported among medical laboratory professionals

Researchers identify neurodevelopmental symptoms that indicate genetic disorders

Oct. 14, 2024

New study from UCLA Health.

Moffitt study unveils the role of gamma-delta T cells in cancer immunology

Oct. 9, 2024

Study marks a significant advancement in the understanding of a specific set of immune cells and its role in patient outcomes in cancer therapy.

Xcell Biosciences expands AmplifyBio collaboration with unique cell and gene therapy manufacturing capabilities

Oct. 3, 2024

The AVATAR Foundry system is a cGMP manufacturing platform that delivers novel capabilities for improving the potency of cell and gene therapies.

Genomics

NIH awards $27M to establish new network of genomics-enabled learning health systems

Sept. 24, 2024

Network will analyze and improve how genomic information is integrated into patient care.

Pillar Biosciences partners with AstraZeneca to help accelerate access to liquid biopsy testing

Sept. 10, 2024

Partnership aims to make liquid biopsy tumor profiling more accessible to local laboratories, clinicians and patients through rapid, affordable, kitted NGS testing solutions.

Genetic Testing

Genetic disease testing

Bipin Chandra Dash, PhD

Aug. 26, 2024

Genetic diseases or disorders are caused due to abnormality or mutations in the genetic makeup. As of July 2024, Online Mendelian Inheritance in Man (OMIM) listed 7,528 single...

6661ca9ac16d6195f8f80048soi_featureditem

State of the Industry: Molecular Diagnostics 2024 survey open through September 6

Aug. 22, 2024

Fill out the survey now.

A genetic analysis of Lyme disease could improve diagnosis and treatment

Aug. 19, 2024

As factors such as climate change help Lyme disease expand its geographic range, this research provides valuable tools and insights for combating this rising public health threat...

Meteorin-like protein drains energy from T cells, limiting immune system’s power to fight cancer

Aug. 7, 2024

New research directed by investigators at the Johns Hopkins University School of Medicine and the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer...

Molecular

Integrated DNA Technologies launches rapid genes and significant upgrades to gene synthesis offerings

Aug. 7, 2024

Advanced Instruments debuts poster on cell count bias at Association for Diagnostics & Laboratory Medicine

Aug. 6, 2024

FDA approves gene therapy to treat adults with metastatic synovial sarcoma

Aug. 5, 2024

High levels of a specific antibody may contribute to acute coronary syndrome

July 25, 2024

Association for Molecular Pathology publishes recommendations to facilitate design and implementation of clinical pharmacogenomic DPYD genotyping assays

July 23, 2024

Precision Medicine

Mass spectrometry’s place in the clinical lab: How it’s used and why

Darren Weber

July 22, 2024

UV radiation damage leads to ribosome roadblocks, causing early skin cell death